Company profilePharmaceutical#354 of 1,318 in Pakistan✓ No DRAP alerts

Pharma Lord (Pvt) Ltd

Pharmaceutical company · 48 brands · 43 molecules

48 registered products 31 pharmaceutical brands 43 distinct molecules 0 DRAP alerts

Company overview

48
registered products
31
pharmaceutical brands
43
distinct molecules
0
therapeutic classes
0
DRAP alerts

Pharma Lord (Pvt) Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 48 product registrations across 43 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Pharma

42 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

42
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202642

Top molecules by brand count

Ceftriaxone4 brands
Azithromycin4 brands
Linezolid3 brands
Cefixime3 brands
Ondansetron2 brands
Fluoxetine2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official55 products · Rs 53.06 – Rs 4,315.12
Median across source: Rs 407.7

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Winlet Pharmaceuticals (Pvt) Ltd. holds 41 molecules not in this portfolio
000 I.UAcyclovirAmlodipineArtemetherCholecalciferolClomifene
STANDPHARM PAKISTAN (PVT) LTD. holds 58 molecules not in this portfolio
AlprazolamAmikacinAmlodipineAmoxicillinAmpicillinArtemether
HIGH - Q INTERNATIONAL holds 118 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant

Get the full profile for Pharma

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.